These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 8598482)

  • 41. Biological inactivation of 5-oxo-6,8,11,14-eicosatetraenoic acid by human platelets.
    Powell WS; Gravel S; Khanapure SP; Rokach J
    Blood; 1999 Feb; 93(3):1086-96. PubMed ID: 9920859
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Exogenous leukotriene B4 (LTB4) inhibits human neutrophil generation of LTB4 from endogenous arachidonic acid during opsonized zymosan phagocytosis.
    Fiedler J; Wheelan P; Henson PM; Murphy RC
    J Pharmacol Exp Ther; 1998 Oct; 287(1):150-6. PubMed ID: 9765334
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Formation of a 5-oxo metabolite of 5,8,11,14,17-eicosapentaenoic acid and its effects on human neutrophils and eosinophils.
    Powell WS; Gravel S; Gravelle F
    J Lipid Res; 1995 Dec; 36(12):2590-8. PubMed ID: 8847485
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The OXE receptor: a new therapeutic approach for asthma?
    Jones CE
    Trends Mol Med; 2005 Jun; 11(6):266-70. PubMed ID: 15949767
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Stereochemical analysis and biological activity of 3-hydroxy-leukotriene B4: a metabolite from ethanol-treated rat hepatocytes.
    Wheelan P; Sala A; Folco G; Nicosia S; Falck JR; Bhatt RK; Murphy RC
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1514-9. PubMed ID: 7996465
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Chemical and biological characterization of oxo-eicosatetraenoic acids.
    O'Flaherty JT; Cordes JF; Lee SL; Samuel M; Thomas MJ
    Biochim Biophys Acta; 1994 Dec; 1201(3):505-15. PubMed ID: 7803484
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Montelukast regulates eosinophil protease activity through a leukotriene-independent mechanism.
    Langlois A; Ferland C; Tremblay GM; Laviolette M
    J Allergy Clin Immunol; 2006 Jul; 118(1):113-9. PubMed ID: 16815146
    [TBL] [Abstract][Full Text] [Related]  

  • 48. 5-Oxo-eicosatetraenoic acid-induced chemotaxis: identification of a responsible receptor hGPCR48 and negative regulation by G protein G(12/13).
    Koike D; Obinata H; Yamamoto A; Takeda S; Komori H; Nara F; Izumi T; Haga T
    J Biochem; 2006 Mar; 139(3):543-9. PubMed ID: 16567419
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Arachidonic acid-induced mobilization of calcium in human neutrophils: evidence for a multicomponent mechanism of action.
    Naccache PH; McColl SR; Caon AC; Borgeat P
    Br J Pharmacol; 1989 Jun; 97(2):461-8. PubMed ID: 2547474
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A biased non-Gαi OXE-R antagonist demonstrates that Gαi protein subunit is not directly involved in neutrophil, eosinophil, and monocyte activation by 5-oxo-ETE.
    Konya V; Blättermann S; Jandl K; Platzer W; Ottersbach PA; Marsche G; Gütschow M; Kostenis E; Heinemann A
    J Immunol; 2014 May; 192(10):4774-82. PubMed ID: 24733850
    [TBL] [Abstract][Full Text] [Related]  

  • 51. 20-Hydroxy- and 20-carboxy-leukotriene (LT) B
    Archambault AS; Poirier S; Lefebvre JS; Robichaud PP; Larose MC; Turcotte C; Martin C; Provost V; Boudreau LH; McDonald PP; Laviolette M; Surette ME; Flamand N
    J Leukoc Biol; 2019 Jun; 105(6):1131-1142. PubMed ID: 30676680
    [TBL] [Abstract][Full Text] [Related]  

  • 52. LTB
    Surmiak M; Gielicz A; Stojkov D; Szatanek R; Wawrzycka-Adamczyk K; Yousefi S; Simon HU; Sanak M
    J Lipid Res; 2020 Jan; 61(1):1-9. PubMed ID: 31740445
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Quantitative analysis of 5-oxo-6,8,11,14-eicosatetraenoic acid by electrospray mass spectrometry using a deuterium-labeled internal standard.
    Powell WS; Boismenu D; Khanapure SP; Rokach J
    Anal Biochem; 2001 Aug; 295(2):262-6. PubMed ID: 11488631
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Activation of the human neutrophil secretory process with 5(S),12(R)-dihydroxy-6,14-cis-8,10-trans-eicosatetraenoic acid.
    Smith RJ; Iden SS; Bowman BJ
    Inflammation; 1984 Dec; 8(4):365-84. PubMed ID: 6097546
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Gas chromatographic/mass spectrometric analysis of oxo and chain-shortened leukotriene B4 metabolites. Leukotriene B4 metabolism in Ito cells.
    Wheelan P; Murphy RC; Simon FR
    J Mass Spectrom; 1996 Mar; 31(3):236-46. PubMed ID: 8799275
    [TBL] [Abstract][Full Text] [Related]  

  • 56. 5-Oxo-6,8,11,14-eicosatetraenoic acid stimulates isotonic volume reduction of guinea pig jejunal crypt epithelial cells.
    MacLeod RJ; Lembessis P; Hamilton JR; Powell WS
    J Pharmacol Exp Ther; 1999 Nov; 291(2):511-6. PubMed ID: 10525065
    [TBL] [Abstract][Full Text] [Related]  

  • 57. 5-Oxo-6,8,11,14-eicosatetraenoic acid is a potent chemoattractant for human basophils.
    Sturm GJ; Schuligoi R; Sturm EM; Royer JF; Lang-Loidolt D; Stammberger H; Amann R; Peskar BA; Heinemann A
    J Allergy Clin Immunol; 2005 Nov; 116(5):1014-9. PubMed ID: 16275369
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Activation of the human neutrophil 5-lipoxygenase by leukotriene B4.
    McDonald PP; McColl SR; Naccache PH; Borgeat P
    Br J Pharmacol; 1992 Sep; 107(1):226-32. PubMed ID: 1330161
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of leukotriene B4, prostaglandin E2 and arachidonic acid on cytosolic-free calcium in human neutrophils.
    Lew PD; Dayer JM; Wollheim CB; Pozzan T
    FEBS Lett; 1984 Jan; 166(1):44-8. PubMed ID: 6319189
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Characterization of an activation factor released from human neutrophils after stimulation by triclinic monosodium urate crystals.
    Desaulniers P; Marois S; Paré G; Popa-Nita O; Gilbert C; Naccache PH
    J Rheumatol; 2006 May; 33(5):928-38. PubMed ID: 16652423
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.